Astilbin Extract Powder/CAS 29838-67-3

Astilbin, 2R, 3R) - citrin-3-O-alpha-L-rhamnoside is a compound first isolated from Astilbin in 1950 by Kozo Hayashi and Kazuhiko Ouchi. According to the literature, Astilbin has many significant biological activities, including inhibition of coenzyme A reductase, inhibition of aldose reductase, protection of liver, analgesia, anti-edema and so on. In recent years, it has been reported that Astragaloside has significant selective immunosuppressive effect, and its selective effect has obvious advantages compared with the previous immunosuppressive agents, so it can be used as a new immunosuppressive agent in the treatment of immune-related diseases.

Preservation: 2-8 degrees C, dry, light-proof and sealed Specification: 20mg 50mg 100mg 500mg 1g 2g, etc. should be packed according to customer's demand. Solubility: soluble in boiling water, almost insoluble in ether Melting point: 180 degree C (decomp) Boiling point: 801.1 +65.0 degree C Density: 1.74 + 0.1 g/cubic centimeter | Conditions: Temperature: 20 degree C PKa: 7.34 + 0.60 | Conditions: Strongest acidic temperature: 25 degree C

Functions and applications: including inhibition of coenzyme A reductase, inhibition of aldose reductase, protection of liver, analgesia, anti-edema and so on. In recent years, it has been reported that Astragaloside has significant selective immunosuppressive effect, and its selective effect has obvious advantages compared with the previous immunosuppressive agents, so it can be used as a new immunosuppressive agent in the treatment of immune-related diseases.